CSRYX
Price
$48.98
Change
+$0.25 (+0.51%)
Updated
Jul 31 closing price
Net Assets
3.16B
RMEBX
Price
$64.44
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
Interact to see
Advertisement

CSRYX vs RMEBX

CSRYX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
CSRYX vs. RMEBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSRYX is a Hold and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. CSRYX (3.16B). CSRYX pays higher dividends than RMEBX: CSRYX (1.34) vs RMEBX (0.99). CSRYX was incepted earlier than RMEBX: CSRYX (12 years) vs RMEBX (12 years). RMEBX (1.07) is less costly to investors than CSRYX (0.68). RMEBX is a more actively managed with annual turnover of: 30.00 vs. CSRYX (28.00). RMEBX has a lower initial minimum investment than CSRYX: RMEBX (250) vs CSRYX (1000000). CSRYX annual gain was more profitable for investors over the last year : 28.90 vs. RMEBX (8.96). CSRYX return over 5 years is better than : 64.64 vs. RMEBX (36.13).
CSRYXRMEBXCSRYX / RMEBX
Total Expense Ratio0.481.0745%
Annual Report Gross Expense Ratio0.681.0764%
Fund Existence12 years12 years-
Gain YTD16.8429.416179%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.16B118B3%
Annual Yield % from dividends1.340.99135%
Returns for 1 year28.908.96323%
Returns for 3 years55.4532.63170%
Returns for 5 years64.6436.13179%
Returns for 10 years137.0490.64151%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEOTX15.100.17
+1.14%
Voya Large Cap Growth Port S2
JRAAX88.86N/A
N/A
Janus Henderson Research A
VLLIX45.39-0.03
-0.07%
Value Line Larger Companies Focus Instl
BHCFX21.68-0.10
-0.46%
Baron Health Care Retail
FBDIX193.96-3.99
-2.02%
Franklin Biotechnology Discovery A